Review



exatecan derivative  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress exatecan derivative
    Exatecan Derivative, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/us12612457-250-1-15?v=MedChemExpress
    Average 93 stars, based on 7 article reviews
    exatecan derivative - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    exatecan derivative  (MedChemExpress)
    93
    MedChemExpress exatecan derivative
    Exatecan Derivative, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/us12612457-250-1-15?v=MedChemExpress
    Average 93 stars, based on 1 article reviews
    exatecan derivative - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    exatecan derived adc  (Daiichi Sankyo)
    86
    Daiichi Sankyo exatecan derived adc
    Exatecan Derived Adc, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/pmc12897389-33-11-4?v=Daiichi+Sankyo
    Average 86 stars, based on 1 article reviews
    exatecan derived adc - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dx 8951 dxd derivative  (MedChemExpress)
    94
    MedChemExpress dx 8951 dxd derivative
    Dx 8951 Dxd Derivative, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/pm38254706-73-6-17?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    dx 8951 dxd derivative - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    glycolic acid derivative of exatecan dxd  (Daiichi Sankyo)
    90
    Daiichi Sankyo glycolic acid derivative of exatecan dxd
    Glycolic Acid Derivative Of Exatecan Dxd, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/pm36650546-97-19-5?v=Daiichi+Sankyo
    Average 90 stars, based on 1 article reviews
    glycolic acid derivative of exatecan dxd - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    camptothecin analog exatecan (dxd; dx-8951 derivative  (Daiichi Sankyo)
    90
    Daiichi Sankyo camptothecin analog exatecan (dxd; dx-8951 derivative
    Characteristics of clinical studies.
    Camptothecin Analog Exatecan (Dxd; Dx 8951 Derivative, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/pmc08269333-35-7-58?v=Daiichi+Sankyo
    Average 90 stars, based on 1 article reviews
    camptothecin analog exatecan (dxd; dx-8951 derivative - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    exatecan mesylate derivative dxd  (BOC Sciences)
    89
    BOC Sciences exatecan mesylate derivative dxd
    Characteristics of clinical studies.
    Exatecan Mesylate Derivative Dxd, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exatecan+derivative/pm31563805-184-20-32?v=BOC+Sciences
    Average 89 stars, based on 1 article reviews
    exatecan mesylate derivative dxd - by Bioz Stars, 2026-07
    89/100 stars
    		  Buy from Supplier

    Image Search Results


    Characteristics of clinical studies.

    Journal: Cancers

    Article Title: Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review

    doi: 10.3390/cancers13133126

    Figure Lengend Snippet: Characteristics of clinical studies.

    Article Snippet: Trastuzumab deruxtecan (DS-8201A, T-Dxd) , HER2 , Camptothecin analog exatecan (DXd; DX-8951 derivative) , Cleavable tetrapeptide linker, Gly-Phe-Leu-Gly (GFLG) , Biliary tract cancer, breast cancer, colorectal cancer, endometrial cancer, lung cancer, salivary glands cancer , I , 60/8 , ECOG: 0–1 , Safety (TEAE), tolerability , In vivo efficacy (CR, DCR, ORR PD, PFS, PR, SD, TTR) , Daiichi Sankyo Inc. , Tsurutani 2020 [ ] , NCT03248492— http://adc.expert/2eYaukS (accessed on May, 16th 2021) NCT03734029— https://clinicaltrials.gov/ct2/show/NCT03734029 (accessed on May 16th, 2021) NCT03523585— https://clinicaltrials.gov/ct2/show/NCT03523585 (accessed on May 16th, 2021) NCT03529110— https://clinicaltrials.gov/ct2/show/NCT03529110 (accessed onMay 16th, 2021).

    Techniques: In Vivo

    Summarizes the design, approved indications and developer of ADCs approved by the FDA.

    Journal: Cancers

    Article Title: Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review

    doi: 10.3390/cancers13133126

    Figure Lengend Snippet: Summarizes the design, approved indications and developer of ADCs approved by the FDA.

    Article Snippet: Trastuzumab deruxtecan (DS-8201A, T-Dxd) , HER2 , Camptothecin analog exatecan (DXd; DX-8951 derivative) , Cleavable tetrapeptide linker, Gly-Phe-Leu-Gly (GFLG) , Biliary tract cancer, breast cancer, colorectal cancer, endometrial cancer, lung cancer, salivary glands cancer , I , 60/8 , ECOG: 0–1 , Safety (TEAE), tolerability , In vivo efficacy (CR, DCR, ORR PD, PFS, PR, SD, TTR) , Daiichi Sankyo Inc. , Tsurutani 2020 [ ] , NCT03248492— http://adc.expert/2eYaukS (accessed on May, 16th 2021) NCT03734029— https://clinicaltrials.gov/ct2/show/NCT03734029 (accessed on May 16th, 2021) NCT03523585— https://clinicaltrials.gov/ct2/show/NCT03523585 (accessed on May 16th, 2021) NCT03529110— https://clinicaltrials.gov/ct2/show/NCT03529110 (accessed onMay 16th, 2021).

    Techniques: